Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-02-07
2010-10-05
Crane, Lawrence E (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07807657
ABSTRACT:
A separate type medical material containing a hyaluronic acid ester derivative, which satisfies the storage stability of a hyaluronic acid ester derivative and avoidance of irritation and pain at the time of injecting a therapeutic agent for joints, is provided. A separate type medical material comprising liquid (A) which is an aqueous solution containing a hyaluronic acid ester derivative and buffered to a pH of from 4.5 to 6.5, and liquid (B) which is an aqueous solution having such a buffering power that when it is mixed with the liquid (A), the mixed liquid has a pH within a range of from 6.8 to 7.8, kept separately from each other.
REFERENCES:
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4605691 (1986-08-01), Balazs et al.
patent: 4713448 (1987-12-01), Balazs et al.
patent: 0 341 745 (1994-12-01), None
patent: 0 216 453 (1996-03-01), None
patent: 2-234689 (1990-09-01), None
patent: 8-104642 (1996-04-01), None
patent: 8-143459 (1996-06-01), None
patent: 10-212303 (1998-08-01), None
patent: 11-302197 (1999-11-01), None
patent: 2001-129073 (2001-05-01), None
patent: 2001-278791 (2001-10-01), None
patent: 2002-35126 (2002-02-01), None
patent: 2002-348243 (2002-12-01), None
patent: 2001-89882 (2001-10-01), None
patent: 2005-7002440 (2005-09-01), None
patent: 63-123392 (1988-05-01), None
patent: 95/25751 (1995-09-01), None
patent: 97/49412 (1997-12-01), None
patent: 99/10385 (1999-03-01), None
patent: 99/15150 (1999-04-01), None
patent: 01/57093 (2001-08-01), None
[R] O'Neil et al. (eds.), The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th Editions, 2001, Merck & Co., Whitehouse Station, NJ, only p. 849 supplied, see entry 4776 (hyaluronic acid).
(S) Swinyard et al., “Pharmaceutical Necessities,” Chapter 66 in Remington's Pharmaceutical Sciences, 18th Ed., Gennaro et al. (eds.), 1990, Mack Publishing Co, Easton, PA, only pp. 1286, 1303-1304 and 1317-1329 supplied.
Seikagaku Data Book 1,The Japanese Biochemical Society, Tokyo Kagaku Dozin Co., LTD., p. 1569 (1979).
Ciba Foundation Symposium 143, The Biology of Hyaluronan, John Wiley & Sons, p. 265 (1989).
Hashimoto Masamichi
Himeda Yasukazu
Miyata Yoshiaki
Miyoshi Teruzou
Umeda Toshihiko
Crane Lawrence E
Denki Kagaku Kogyo Kabushiki Kaisha
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Separate type medical material does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Separate type medical material, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Separate type medical material will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4238500